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One  of the  major concerns  of contemporary  immunology  is  the  elucidation  of 
mechanisms of regulation of the immune response. The study of suppressor and helper 
functions in experimental animal models has uncovered important roles for immune 
response  genes  (1,  2).  There  is  limited  evidence  that  there  are  genetic  restrictions 
operating to control suppression of certain in vitro immune responses in man (3, 4). 
The principal experimental model for studying human suppressor cell generation and 
function remains the mitogen-induced suppressor response in vitro (5, 6). Suppressor 
functions  induced  by  exposure  of  lymphocytes  to  concanavalin  A  operate  in  a 
nonspecific and apparently genetically nonrestricted  fashion and appear capable of 
suppressing  both  human  cell-mediated  and  humoral  functions.  Human  mitogen- 
induced lymphocyte suppression has been shown to be effected by a specific subset of 
T  lymphocytes (7); however, the mechanism of suppression remains largely unknown. 
Originally defined by their antiviral activity, interferons have recently been found 
to exert a variety of other biological activities, which include inhibition of cell division 
(8), enhancement of phagocytosis (9), alteration of expression of cell surface antigens 
(10), and regulation of immune responses. Included in the immunoregulatory activities 
of interferons are their ability to augment cytotoxic activity of natural  killer  (NK) x 
cells (11)  and their ability to suppress cell-mediated responses both in vivo (12)  and 
in vitro (13,  14). It is now clear that there are different molecular entities that possess 
antiviral  activities.  Perhaps  the  best  studied  interferon  (IF)  is  that  produced  by 
challenge of fibroblasts or tissue culture cell lines with viruses. Stimulation of human 
leukocytes with virus causes the production of an immunologically noncross-reactive 
species of IF known as type I or leukocyte IF. Activation of primed T  cells by specific 
antigens such as purified protein derivative (PPD) or mitogens is known to engender 
the production  of a  third  type of IF known  as type II or immune IF. These three 
species of IF have been described as possessing distinct molecular characteristics and 
are thought to be antigenically distinct (15-17). Both leukocyte (type I) and fibroblast 
IF have been described as being stable at acid pH and heat labile. Type II IF is acid 
labile and stable at 56°C. 
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Because of the well-described imrnunosuppressive activities of IF, and the fact that 
mitogens are  known  to  stimulate  the  production  of IF  by  lymphocytes,  we  have 
examined the role of IF in the in vitro suppressive activity of concanavalin A  (Con 
A)-activated human peripheral blood mononuclear cells. The results presented here 
will indicate that the suppressor activity of Con A-activated cells is mediated largely 
by IF and that  similar suppressor activity can be generated by exposure of human 
peripheral  blood leukocytes  (PBL)  to certain tumor cell  lines, viruses, and specific 
antigen, which induce the production of IF. 
Materials and Methods 
Lymphocyte Preparation and Culture.  PBL were prepared from venous blood by heparinization 
followed by Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piseataway, 
N. J.)  sedimentation. For those  experiments with the virus plaque assay  (VPA)  defibrination 
was used (18). Culture medium for all experiments was RPMI-1640 (Grand Island Biological 
Co., Grand Island, N. Y.) supplemented with  10% pooled human AB serum, glutamine, and 
antibiotics. PBL were cultured at 1 ×  106 cells/ml of medium in 5-ml plastic tubes for the VPA 
(2 ml of cell suspension/tube) or in flat-bottomed microtiter plates (0.2 ml/well) for measure- 
ment of tritiated thymidine ([3H]TdR) incorporation. All cultures were done in triplicate. Con 
A (Miles Laboratories Inc., Miles Research Products, Elkhart, Ill.) was added to cultures at a 
final concentration of 30  /~g/ml.  Cultures were  incubated at  37°C  in  a  humidified CO2 
incubator for 72 h before addition of|3H]TdR or infection with virus. 
VPA and Assay for Incorporation of [~  -H]TdR.  The VPA for  enumerating activated  human 
lymphocytes was carried out as described previously (18). Briefly,  lymphocytes were infected 
with vesicular stomatitis virus (VSV)  at the end of the culture period, treated with guinea pig 
anti-VSV serum to neutralize free virus, washed, and plated over an indicator monolayer of 
L929  cells  in  an  infectious centers  assay.  Virus  plaque-forming cells  (V-PFC)  were  then 
enumerated and expressed  as V-PFC per 106 cells plated. Aliquots (0.2 ml) of the same cultures 
tested for V-PFC were removed before infection with virus and placed in microtiter wells. For 
assay of lymphocyte transformation, 1/~Ci of [3H]TdR (New England Nuclear, Boston, Mass.) 
was added to each sample in microtiter wells. Samples were harvested 6 h later in a multiple 
cell  culture harvester  (Skatron, Flow Laboratories,  Inc., Rockville, Md.)  and counted in a 
Beckman liquid scintillation counter  (Beckman Instruments, Inc., Spinco Div.,  Palo  Alto, 
Calif.). 
Generation of Modulator Cells and Supernates with Con A and PPD.  Modulator cells were prepared 
by culture of 2 ×  106 PBL in 2 ml in plastic tubes with or without Con A (30/xg/ml) or PPD 
(20 #g/ml) for 72 h. PPD was obtained from the Ministry of Food, Fishery, and Agriculture, 
Weybridge, Surrey, England. In the case of Con A, modulator cells were washed with 0.1  M 
a-methylmannoside to remove residual Con A.  Modulator cells  (1  ×  106) were  then treated 
with mitomycin C  (50 ~g/ml for  30  rnin at  37°C)  and added  to equal numbers of freshly 
prepared  autologous or  allogeneic responder  cells,  cultured  for  an  additional  72  h  in  the 
presence or absence of Con A, and then assayed for V-PFC or incorporation of [3H]TdR. In the 
case of PPD-activated modulator cells, PPD-negative responder PBL were used. In experiments 
with modulator supernates, supernates from Con A- or PPD-activated PBLand from PBL 
cultured in medium alone were added to responder lymphoeytes at a final dilution of 1:1  in 
culture medium in the presence and absence of Con A and assayed for [3H]TdR incorporation 
after a 72-h incubation. 
Tumor Cell-Lymphocyte Cocultures.  Tumor cell-lymphocyte cultures were carried out  as  re- 
ported by Trinchieri and Santoli (11) with 5 ×  10  ~ tumor cells and 5 ×  l0  s PBL in  16-mm 
wells. As controls, lymphocytes were cultured in the absence of tumor cells, and tumor cells in 
the absence of lymphocytes. Lymphocytes and supernates were harvested after 24 h. Lympho- 
cytes to be used as modulator cells were treated with mitomycin C and added to equal numbers 
of freshly  prepared autologous or allogeneic responder cells.  Supernates from these.cultures 
were centrifuged at 400 g, millipored to remove cell debris, and added to responder cells at a 
final concentration of 10%  in culture medium. Modulator-responder cultures were cultured 
with or without Con A for 72 h before infection with virus or addition of [3H]TdR. Tumor lines KADISH, TANSEY,  YU,  DOYLE,  AND BLOOM  639 
tested included a human melanoma line, MeWo (19); a human breast carcinoma line, MCF-7 
(20)  (obtained from Jorgen Fogh, Sloan-Kettering Institute for Cancer Research, Rye, N. Y.); 
two  human  bladder carcinoma  lines,  T24  (21);  and  TCCSUP  (22)  (obtained  from  Carol 
O'Toole of the London Hospital Medical College, London, England), HeLa, and HeLa-Ms, a 
HeLa line persistently infected with measles virus (23)  (obtained from John  Holland of the 
University  of California,  San  Diego,  Calif.).  All  tumor  lines  were  shown  to  be  free  of 
contamination by mycoplasma when stained with Hoechst dye 33258 (Hoechst Ag., Frankfurt, 
Federal Republic of Germany) (24). 
Newcastle Disease Virus (NDV)  Treatment of PBL.  NDV was grown in chick embryo fibro- 
blasts, harvested at  the  time of maximal cytopathic effect, yielding 5  ×  10  7  PFU/ml,  and 
inactivated with fl~6propiolactone  (0.15%,  37°C, 2 h)  (25). Ficoll-Hypaque-prepared PBL were 
euhured at 2 ×  10  cells/ml with inactivated NDV  (10~/ml) at 37°C for 48 h. IF-containing 
supernates were centrifuged at 30,000 g at 4°C for 3 h to remove virus. The supernate used in 
all experiments contained 3,170 U  of antiviral activity/ml. 
Computation of Percent Suppression.  Percent suppression was calculated as follows: 
Con A response of treated modulator -  responder cultures ] 
% suppression =  1 -  Con A response of control modulator -  responder cultures .j ×  100, 
where the Con  A  response was the Con A-induced V-PFC or counts per minute minus the 
background (unstimulated) V-PFC or counts per minute. Treated modulators included cells 
exposed to Con A, PPD, NDV, or tumor cell lines or their supernates. Control modulators were 
PBL cultured in medium alone or their supernates. For tumor coculture experiments, supernates 
from tumor cells and lymphocytes alone were used as controls in determining percent suppres- 
sion by cocuhure supernates. 
Assay for Antiviral Activity.  IF was assayed by the reduction of the eytopathic effect of VSV 
on  human  21  trisomic  fibroblasts  (Detroit  532,  American  Type  Cell  Culture  Collection, 
Rockville, Md.).  0.10-ml  samples of supernate  and  serial half log dilutions were  added  to 
fibroblast monolayers (104 cells/well) in microtiter wells. After an  18 h  incubation, 5  ×  104 
PFU of VSV were added to each well. The IF titer was determined 48 h later as the reciprocal 
of the highest dilution that inhibited 50% of the cytopathic effect. Each assay included a human 
reference IF preparation (G-023-901-527, National Institutes of Health). 1 U of IF in our assay 
system corresponded to 0.6 reference units. 
Anti-Human  Leukocyte IF Sera.  Rabbit anti-human leukocyte IF serum was prepared by Dr. 
K. Paucker (Medical College of Pennsylvania, Philadelphia, Pa.) (and kindly provided by Dr. 
G. Galasso, Infectious Disease Branch,  National Institute of Allergy and Infectious Diseases, 
Bethesda, Md.). This serum was raised against Sendai virus-induced leukocyte IF and has an 
antibody titer of 10,000  U/ml  against human  leukocyte IF and  240  U/ml  against  human 
fibroblast IF. The antiserum was added to modulator-responder cultures at a final dilution of 
1:100  at the start of the culture period. A  sheep anti-human leukocyte interferon serum was 
kindly provided by Dr. K. Cantell (Central Public Health Laboratory, Helsinki, Finland) and 
was similarly used in some experiments. 
Treatment at pH 2.  Supernates were dialyzed 24 h  at 4°C in RPMI  (pH  7.4)  or in RPMI 
acidified to pH 2 by addition of 4 N  HCI and then dialyzed an additional 24 h in RPMI. All 
supernates were checked for pH at the end of the dialysis period and millipored. Supernates 
were assayed for antiviral activity and suppression before and after dialysis at pH 7.4 and pH 
2. 
Results 
Suppression  by  Con  A-activated Modulator  Cells.  In  our  initial studies, we compared 
the effects of Con A-induced modulator cells in two assays for lymphocyte activation, 
the lymphocyte transformation test and the VPA. The latter enumerates activated T 
cells by their ability to permit replication of VSV  (18).  Lymphocytes treated for 3 d 
with or without Con A  were treated with mitomycin C  and used as modulator cells, 
which could influence the response of normal responder lymphocytes to Con A. The 
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F[c.  1.  Con  A-induced  suppression of the  mitogen  response measured  in  the  VPA  and  in  the 
thymidine incorporation assay. The data represent the mean suppression obtained from 15 separate 
experiments with autologous or allogeneic responder-modulator combinations. Suppression in the 
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FIo.  2.  Effect  of anti-human leukocyte IF serum on the Con A response as measured in the VPA 
(open  circles)  and  in  the  [SH]TdR  incorporation  assay  (closed  circles).  The  lower  two  curves 
represent the values for unstimulated PBL, the upper for Con A-stimulated cultures. Values shown 
are means of triplicate cultures :1: SD. 
response of freshly prepared  PBL was  invariably greater in  the  VPA  than  in  the 
[SH]TdR incorporation assay done on the same cultures (Fig.  1). The mean percent 
suppression in a group of 15 normals observed in the VPA was 82.7% compared with 
47.2% in the [SH]TdR assay. As reported by others (5), Con A-treated modulator cells 
were equally effective in suppressing the mitogen response of autologous or allogeneic 
responders. 
Effect  of Anti-Human  Leukocyte IF Serum on  Con A-stimulated  PBL.  To explain  the 
increased sensitivity of the VPA to the action of Con A-activated modulator cells, we 
considered the possibility that mitogen-induced IF might contribute to the observed 
suppression, perhaps affecting the generation of cells permissive to viral replication to 
a  greater extent than  the incorporation of [SH]TdR. To ascertain  whether IF was 
involved in  the  suppression,  we  first  investigated  the  effect of adding  rabbit  anti- 
human leukocyte IF serum to mitogen-stimulated cultures, and found that the number 
of Con  A-stimulated  V-PFC  was  increased,  often  as  much  as  200%,  whereas  the 
[SH]TdR  incorporation  in  the  same  cultures  increased  by  only  10-30%  in  most 
experiments. Unstimulated cultures (no Con A  added)  were unaffected by addition 
of the antiserum.  A  representative experiment is shown  in  Fig.  2.  There was  some 
variation from donor to donor in sensitivity to the anti-IF serum, perhaps reflecting 
genetic differences in levels of IF production between different individuals, analogous 
to strain differences among mice (26) or production of different proportions of types 
I and II IF (see below). KADISH, TANSEY,  YU,  DOYLE,  AND BLOOM  641 
TABLE  I 
Effect of Anti-Human Leukocyte IF Serum on Suppression of Con A Responses by Con A- 
stimulated Modulator Cells 
Treatment of modulator  IF~  VPA  [3H]TdR incorporation as- 
cells*  say 
U/ml  V-PFC/IO  s cells§  % sup-  cpm§  % sup-  pression  pression 
Control  10  48,936  (2,463)  --  118,699  (16,425)  -- 
Con A  100  19,132  (4,821)  61%  62,765  (4,243)  47% 
Control + Anti-IF serum  0  54,142  (6,310)  --  116,032  (11,031) 
Con A + Anti-IF serum  10  46,875  (9,722)  13%  98,650  (5,834)  15% 
* Modulator cells prepared by preincubation  in medium  (control) or Con A for 72 h and 
added to freshly prepared responder cells in the presence and absence of Con A. Rabbit 
anti-human leukocyte IF added at a final concentration of 1:100 in culture medium at the 
start of the culture period. 
~: IF titers of modulator-responder cultures assayed on D532 cells. 
§ V-PFC  and  cpm  values  cited  represent  Con  A-stimulated  values  minus  background 
(unstimulated)  values. Standard deviations of the mean are shown in parentheses. 
Supernates of Con A-activated PBL from normal individuals generally contained 
100 U  of IF/ml. Antiviral activity was virtually all (90-100%) eliminated after dialysis 
at  pH  2,  compatible with  type  II  or  immune  IF.  Addition  of rabbit  anti-human 
leukocyte IF to supernates of Con A-activated PBL before IF assay reduced antiviral 
titers by 70%  in most experiments. This antiserum, which was raised against Sendai 
virus-induced  leukocyte  (type  I)  IF,  thus  was  able  to  neutralize  a  portion  of the 
antiviral activity of pH 2 labile mitogen-induced IF, which suggested either antigenic 
cross-reactivity between  viral-  and  mitogen-induced  IF  or,  alternatively,  that  the 
antiserum  has  multiple  specificities. Similar  reduction  of the  antiviral  activity  of 
supernates of Con A-activated PBL was observed with a  sheep anti-human leukocyte 
IF serum in two experiments. 
Addition  of  Anti-Human  Leukocyte  1F  Serum  to  Con  A-treated  Modulator-Responder 
Cultures.  The role of IF in the Con A  suppressor system was established when it was 
found in five separate experiments that the presence of anti-IF serum largely abrogated 
the Con A-induced suppression of the mitogen response. A  representative experiment 
is shown  in Table I. IF titers were often, but  not  always, significantly higher in the 
supernates  of suppressed cultures.  Culture  supernates  that  contained  anti-IF serum 
showed  partial loss of antiviral activity in  parallel with  loss of suppression.  Similar 
results were obtained with both sheep and rabbit anti-IF sera. Suppression of mitogen 
responses by supernates of Con  A-activated ceils was  also abrogated by addition of 
anti-IF to supernate-treated responder cells. 
Suppression  by PPD-activated Modulator Cells.  When  PBL  from PPD-positive donors 
were  cultured  in  the  presence  of PPD  for 48  h,  significant  suppressor  activity was 
obtained  when  these  modulator  cells were  added  to  PPD-negative  responder  PBL 
stimulated with  Con  A.  Supernates of such  PPD-treated  modulator cells contained 
100-1,000  U  of antiviral activity and  suppressed the Con  A  responses of responder 
PBL.  Conversely,  modulator cells or supernates  prepared  from  PPD-negative  PBL 
treated with PPD  failed to suppress or to exhibit antiviral activity. A  representative 
experiment is shown  in Table II. PBL  from some PPD-negative donors did produce 
1-3  U  of  IF  that  was  acid  stable,  neutralized  by  anti-IF  serum,  and  capable  of 642  INTERFERON  AS A MEDIATOR  OF HUMAN  LYMPHOCYTE  SUPPRESSION 
TAnLE II 
Suppression of Con A Response by Modulator Supemates  from PPD-Positive and PPD- 
Negative Donors 
[SH]TdR incorpora-  IF* 
tion 
% suppres-  U/ml  cpr~lp  sio. 
PPD-positive donor  S 
Modulator supernate from:§ 
Lymphocytes cultured alone 
Lymphocytes cultured with PPD 
Lymphocytes cultured with Con A 
PPD-negative donor:]: 
Modulator supernate from:§ 
Lymphocytes cultured alone 
Lymphocytes cultured with PPD 
Lymphocytes cultured with Con A 
124,942 (6,812)  --  <3 
81,236 (8,858)  36%  300 
101,460 (3,726)  19%  30 
116,596 (8,712)  --  <3 
114,407 (2,488)  2%  3 
83,794 (6,107)  25%  30 
* IF titers of modulator (PPD- or Con A-treated) or control supernates. 
$ PPD-positive donor gave a  [SH]TdR response of 22,432 cpm over background in the 
presence of PPD. PPD-negative  donor gave [aH]TdR response  of 300 cpm over background. 
§ 48-h supernates of PBL cultured in medium or PPD and added to PPD-negative responder 
cells in the presence of Con A at a final concentration of 1  : 1 in culture medium. 
II Results shown are  mean  cpm  of triplicate  cultures stimulated  by  Con  A.  Standard 
deviations of the mean are shown in parentheses. 
priming for the induction of IF by virus, thus appearing to be type I IF. At these low 
levels (0.5-1.5 U/ml in final culture medium), significant suppression by modulator 
cells or supernates was not seen. As will be shown in a later section (Fig. 5) supernates 
of PPD-activated PPD-sensitive PBL  had  antiviral activity that  appeared  to  be  a 
mixture of type I and type II IF. 
Generation of Suppressor Cells, Soluble Suppressor Factors, and IF by Lymphocyte-Tumor  Cell 
Coculture.  To test the generality of the suppression of lymphocyte activation by IF, 
normal human PBL were cultured overnight on monolayers of several tumor cell lines 
in a protocol similar to that described by Trinchieri and Santoli (1 1)  for inducing IF 
production by NK cells. Results of a  representative experiment with MeWo MCF-7 
cell lines are shown in Table III. Lymphocytes removed from the MeWo cells after 
overnight incubation were themselves suppressed and strongly suppressed the Con A 
responses of freshly prepared  responder cells, whereas  lymphocytes cultured in the 
absence of melanoma cells  failed  to  suppress.  Supernates from  the  mixed cultures 
contained significant amounts of IF, whereas supernates from lymphocytes or mela- 
noma cells cultured alone had no measurable antiviral activity. In some experiments, 
supernates from MeWo cells cultured alone suppressed and induced IF. IF induction 
and suppression by these supernates could be abolished by milliporing or by repeated 
freeze-thawing, a procedure that did not affect the antiviral or suppressor activities of 
IF-containing  supernates. When added to responder cells after milliporing or freeze- 
thawing,  only the  MeWo-lymphocyte supernates  suppressed.  In  experiments with 
modulator lymphocytes cultured on tumor lines, we were concerned that tumor cells 
might  be carried  over  into modulator-responder cultures.  Mitomycin treatment  of 
PBL  did not significantly affect  their ability to  make IF on coculture with  MeWo 
cells; however, mitomycin-treated MeWo cells were unable to induce IF or suppressor KADISH, TANSEY, YU,  DOYLE, AND BLOOM  643 
TABLE III 
Generation of Suppressor Cells, Soluble Suppressor Factor, and IF in Tumor Cell-Lymphocyte Cultures 
IF~  VPA  [3H]TdR incorporation as- 
say 
U/ml  V-PFC/  IO  ~ cells§  % sup-  cpm§  % sup-  pression  pression 
--  20,138  (2,333)  --  60,166 (7,813)  -- 
--  1,414 (12)  93%  24,269  (3,018)  60% 
Modulator cells* 
Lymphocytes cultured alone 
Lymphocytes cultured with 
MeWo cells 
Modulator supernates from:* 
Lymphocytes cultured alone  0 
Lymphocyte-MeWo  culture  317 
MeWo cells alone  0 
36,052 (13,412)  --  71,541 (11,03l)  -- 
177 (230)  99% II  37,911  (2,990)  41% II 
24,342 (1,885)  --  56,916 (3,646)  -- 
Lymphocytes cultured alone  0  ND  120,434 (7,532)  -- 
Lymphocyte-MCF-7  culture  0  ND  127,969 (7,965)  -5% ]] 
MCF-7 cells alone  0  ND  123,362 (4,036)  -- 
* Freshly prepared  responder cells treated  with  modulator cells or modulator culture supernates and 
cultured in the presence and absence of Con A. 
IF titers of modulator supernates assayed on D532 cells. 
§ V-PFC and cpm values cited represent Con A-induced values minus background (unstimulated) values. 
Standard deviations of the mean are shown in parentheses. 
[] Percent suppression calculated with mean of the two control supernates (lymphocytes  alone and tumor 
cells alone). 
factor from PBL. It would thus appear that tumor cells carried over with modulator 
cells would not themselves cause suppression. 
Both modulator cells and supernates exerted greater suppressive activity with the 
VPA than the [aH]TdR assay, as noted previously in experiments with Con A-treated 
modulators. A human mammary carcinoma line, MCF-7, failed to induce suppression 
of the mitogen response, and no antiviral activity could be detected in supernates of 
lymphocyte-MCF-7 cocultures.  Similarly, the  T24  and  TCCSUP  human  bladder 
carcinoma  lines  and  HeLa  cells  failed  to  induce  IF  or  suppression.  HeLa  cells 
persistently infected with measles virus (HeLa-Ms) induced both IF and suppression. 
The results are summarized in Fig. 3. 
Addition of anti-human leukocyte IF serum  to  lymphocyte-tumor cell coculture 
modulator-responder cultures largely eliminated suppression by modulator cells and 
significantly reduced suppression by supernates. Treatment at  pH  2  did  not  affect 
suppression by lymphocyte-tumor cell supernates, Similarly, the antiviral activity of 
these preparations was unchanged by pH 2, but was fully neutralized by anti-human 
leukocyte IF serum. (Results summarized in Fig. 5.) 
Suppression  of the Con A  Response  by ND V-induced IF.  A supernate from PBL treated 
with fl-propiolactone-inactivated NDV contained 3,170 U  of IF/mi. In the presence 
of  varying  dilutions  of  this  material,  the  Con  A  response  of  normal  PBL  was 
suppressed. A representative experiment is shown in Fig. 4. Significant suppression of 
the Con A response was seen at final concentrations of <  1 antiviral U/ml of culture 
suspension, thus demonstrating that viral-induced leukocyte IF is a  potent immuno- 
regulatory  substance even  at  concentrations undetectable  by  a  sensitive antiviral 644  INTERFERON AS A MEDIATOR OF  HUMAN LYMPHOCYTE SUPPRESSION 
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FIG. 4.  Suppression of Con A response by NDV-induced leukocyte IF, and abrogation of suppres- 
sion by anti-human  leukocyte IF serum. Graded  doses of IF were added  to PBL stimulated  with 
Con A in the presence of normal  rabbit  serum (open circles) or rabbit  anti-human  leukocyte IF 
(closed circles). Values shown represent the mean of triplicate cultures + SD. 
assay.  Sensitivity of responder  PBL to added  IF was variable; some donors failed to 
be suppressed  at  levels of <  3  U/ml. Addition of anti-human  leukocyte IF serum to 
these cultures completely eliminated suppression of the Con A response. Similarly the 
antiviral  activity  of this  preparation  was  completely  abolished  by  this  antiserum. 
Antiviral activity was unaffected by treatment  at  pH 2. 
Antiviral  and Suppressive Activities  of Supernates  Produced by  Various IF Inducers.  To 
determine whether suppression and antiviral activity are mediated by the same type(s) 
of IF, supernates  from PBL cultured with Con A, NDV, PPD, and MeWo cells were 
dialyzed at pH 2, treated with anti-IF serum, or both, and were assayed for antiviral 
and  suppressive  activity. A  representative experiment  is shown  in  Fig.  5.  From  the 
results shown  it can be seen  that  the IF induced by  NDV and  MeWo cell coculture 
are neutralized by anti-IF serum  but  unaffected by  pH  2.  Similarly, suppression  by 
these supernates  is eliminated or markedly reduced by anti-IF but  unaffected by pH 
2  treatment.  As shown  in  Fig.  5,  addition  of anti-IF to  tumor  cocuhure  supernates 
was  unable  to completely abrogate  suppression  as  was  the  case with  NDV-induced KADISH, 
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Fro.  5.  Antiviral and suppressive activities of supernates of PBL treated with different IF inducers: 
effect of treatment with anti-human leukocyte IF serum and dialysis at pH 2. Supernates of PBL 
treated with NDV, Con A, PPD, and MeWo cells were diluted with medium to contain 100 U  IF/ 
ml. and dialysed at  pH  2 or treated  with anti-IF serum or both. Supernates of PBL cultured in 
medium  alone  were  similarly  treated.  Modulator  and  control  supernates  were  then  added  to 
responder PBL  (PPD negative)  in the presence of Con A.  [aH]TdR  incorporation  was measured 
after 72 h, and percent suppression was calculated. Treated and untreated modulator supernates 
were assayed for antiviral activity on D532 ceils. Dialysis at pH 7.4 had no effect on suppressive or 
antiviral activity. 
IF, which suggested  that  factors other than  IF may also contribute to tumor cell- 
induced suppression. The Con A- and PPD-induced antiviral and suppressive activi- 
ties appeared to be a mixture of classical type I and type II IF in that both pH 2 and 
anti-IF reduced both activities, whereas a combination of the two treatments elimi- 
nated them completely. It can be seen that suppressive and antiviral activities were 
affected in parallel in all cases, thus offering strong support that IF is a  mediator of 
suppression in this system. 
Discussion 
In the past several years two major mechanisms of immunological suppression have 
been described, one specific the other not. The first to be described (27,  28)  was a 
nonspecific suppression of antibody formation in vitro induced by mitogen stimulation 
of lymphocytes from experimental animals.  Both mitogen-treated lymphocytes and 
soluble factors produced by them were found capable of restricting cellular immune 
responses  as  well  (29).  The  soluble  factor  responsible,  termed  "SIRS"  (30),  had 
properties similar to migration inhibitory factor and has more recently been shown to 
be  capable  of correcting  the  defect  in  NZB  mice  in  vivo  responsible  for  their 
developing autoimmune disease  (31). The second mechanism of regulation demon- 
strated  in  experimental animals was  the antigen-specific and  genetically restricted 
control of antibody formation and cell-mediated immune reactions controlled by T 
cells  (1).  Recently,  evidence  has  been  provided  that  indicates  that  this  type  of 
suppression can be mediated by a molecule that possesses  specificity for antigen and 
determinants of I-region gene products (32). 
Because of the difficulty in carrying out studies on genetic restrictions in man, there 
are  only  a  limited  number  of experiments  that  confirm  the  existence  of human 
genetically  restricted  or  antigen-specific  T  cell-mediated  suppression  (3,  4).  The 
principal tool used to study defects in the cell-mediated immunosuppressive mecha- 646  INTERFERON  AS A MEDIATOR OF HUMAN LYMPHOCYTE SUPPRESSION 
nism  has  been  the study of mitogen-induced suppressor cell activity. Considerable 
evidence exists that indicates that mitogen-activated human lymphocytes can suppress 
both in vitro cell-mediated and antibody responses, and that defects in this mechanism 
have been identified in such clinical entities as multiple sclerosis (33), lupus erythe- 
matosis (34-36), and autoimmune syndromes (37). 
Although there is compelling evidence that T cells are involved in mitogen-induced 
suppression,  it has not been possible to demonstrate rigorously that  T  cells are the 
only cells  capable  of mediating  this  response.  In  any  case,  the  mechanism  of the 
mitogen-induced suppressor activity of human  lymphocytes and  the nature of the 
soluble suppressor factor has not been elucidated. 
The possible role of IF in Con A-induced suppressor activity of human lymphocytes 
was  suggested  by the  finding that  when  two assays of lymphocyte activation were 
used  as  the detection system for monitoring Con A-induced suppression,  the VPA 
invariably showed higher levels of suppression than did the incorporatio  n of [3H]TdR. 
Because the virus used to detect lymphocyte activation in the VPA was VSV, known 
to be a  sensitive indicator virus for IF assay,  it  seemed likely that  the  increase in 
sensitivity to Con A suppressor activity shown in the VPA was related to the sensitivity 
of the virus system for detecting IF activity. Although IF are defined by their antiviral 
activity,  it  is  clear  that  they  are  capable  of exerting a  variety of functional  and 
molecular changes in a variety of cell types (38), At least three molecular species that 
possess  IF activity have been defined. A  number of laboratories have reported that 
one or more types of IF were capable of inducing suppression  of T  cell or B  cell 
responses in vivo and in vitro (12-14, 39). 
The data presented here confirm an immunoregulatory function of IF and suggest 
that  they may be  the  principal  agents  mediating  mitogen-induced suppression  of 
lymphocyte activation measured in vitro. The evidence in support of this conclusion 
is derived from the following observations:  (a) There was a  correlation between the 
suppressive activities of Con  A-treated modulator lymphocytes and  their ability to 
produce IF in  vitro.  (b)  There was  a  parallel  between  the suppressive activities of 
supernates of Con A-stimulated lymphocytes and their antiviral activity. (c)Culture 
supernates that contained IF induced by virus or tumor cell coculture or by antigen 
(PpD) mimic the effect ofmitogen-induced suppressor cells and supernatants. (d) The 
suppressive activities of Con  A-stimulated  lymph0cytes or their culture supernates 
were markedly inhibited by two different~ antisera prepared against human leukocyte 
IF.  At  present, we are unable to exclude the possibility that  factors other than  IF 
contribute to suppression in this system. 
By the indirect means available, it is difficult to define rigorously the species of IF 
that  effects  the  nonantivirat  activities  being  studied.  In  our  experiments,  NDV- 
induced  IF  from  human  leukocytes  was  found  to  be  entirely  pH  2  stable  and 
completely neutralized by a  rabbit and sheep anti-human  type I  leukocyte IF, and 
behaved as classically defined type I  leukocyte IF.  The  PPD-induced  immunosup- 
pressive and antiviral activities were found to be partially pH 2 labile and partially 
affected by the antibodies to type I leukocyte IF, but completely neutralized by both 
treatments, thus having characteristics of a  mixture of both types of IF. The immu- 
nosuppressive and antiviral activities produced by the interaction of normal human 
leukocytes and human tumor cells had the properties of type I leukocyte IF. The Con 
A-induced suppressor and  antiviral  activity shared properties with both type I  and KADISH, TANSEY, YU, DOYLE, AND BLOOM  647 
type II IF. It was largely inactivated by treatment at, pH 2, and yet 70% of the activity 
was  abolished  by  treatment  with  anti-type  I  leukocyte  IF  antiserum.  Although 
alternative explanations are possible, e.g., that anti-type I  IF sera have some cross- 
reactivity with type II IF, or that there exists a subset of type I IF molecules that are 
pH 2 labile, the simplest interpretation would be that Con A- and PPD-stimulated 
human PBL produce both type I and type II leukocyte IF that mediate the observed 
suppressor activity. On  the  basis  of the antibody neutralization studies, we would 
assume that ~  70% of the suppressor activity of Con A-activated cells is mediated by 
type I leukocyte IF, and that 30%, not neutralizable with these sera, would represent 
type II IF. Because it has been clearly demonstrated that T  cells can produce type II 
IF (40)  and that a  non-B non-T subset with characteristics of NK cells can produce 
type I  IF (41), we would conclude that both lymphocyte subsets may be stimulated 
by Con A to carry out suppressor function in vitro. 
We believe that  the results  described here might  have useful application  to the 
study of a  number of human diseases, including lupus erythematosis and  multiple 
sclerosis,  in  which  a  defect  of mitogen-induced  suppression  has  been  described. 
Whether the primary defect is truly an immunoregulatory one, or is related to the 
failure to produce or to respond to IF might provide useful insights into the etiology 
and pathogenesis of these conditions. In this regard, it is of interest that there was a 
defect in virus-induced suppression in 32 of 36 patients with multiple sclerosis that 
was paralleled precisely by their inability to produce IF (42).  Recently it has been 
reported that immune IF is elevated in the serum of some patients with autoimmune 
disease (43). 
Secondly, Trinchieri and Santoli (11)  reported that some human tumor cell lines 
are capable of stimulating  the production of IF from normal human  lymphocytes, 
whereas others are not. In the present experiments, we have confirmed this observation 
and extended it to demonstrate a parallel between their ability to induce IF and their 
ability to engender suppressor cells. Because of the importance of IF as an immuno- 
regulatory molecule capable of stimulating  NK cell activity and  its  demonstrated 
suppressor activity on lymphocyte, presumably T  cell, activation, it will be of interest 
to study the antiviral  and suppressive response of lymphocytes from patients  with 
various forms of cancer to search for immunoregulatory defects in that disease. 
Summary 
Evidence  is  presented  that  interferon  (IF)  is  a  major  mediator  of the  human 
concanavalin A  (Con A) suppressor cell. The suppressive effects of Con A-activated 
lymphocytes on the mitogen responses of normal responder cells were largely abro- 
gated by addition of anti-human leukocyte IF serum. Similar suppressor activity was 
generated by coculture of peripheral blood leukocytes (PBL) with a  melanoma cell 
line (MeWo) and a HeLa cell line persistently infected with measles virus that induced 
the production of IF by lymphocytes. A  human mammary carcinoma line (MCF-7) 
and  two  bladder  carcinoma  lines  (T24  and  TCCSUP)  failed  to  induce  IF  or 
suppression.  Addition  of anti-human  leukocyte IF  serum  to  suppressor  cells  and 
supernates from tumor cell-lymphocyte cocuhures largely abolished suppression and 
neutralized the antiviral activity of such supernates. Exposure of PBL from purified 
protein derivative (PPD)-positive donors to PPD caused the production of suppressor 
activity and IF. PBL from PPD-negative donors failed to produce significant amounts 648  INTERFERON AS A MEDIATOR OF HUMAN LYMPHOCYTE  SUPPRESSION 
of IF or to suppress  on exposure  to PPD.  Supernates  from PBL treated  with  virus 
(Newcastle disease virus [NDV]) contained IF and suppressed  the mitogen responses 
of responder  PBL.  Both the suppressive  and  the antiviral  activities  of this  material 
were eliminated  after  treatment  with  anti-IF serum.  To ascertain  whether antiviral 
and  suppressive  activities  were mediated  by the same  types of IF,  supernates  from 
PBL cultured  with  Con A,  PPD,  NDV,  and  tumor cells were  treated  with  anti-IF 
serum  or  acid  pH.  In  all  cases  antiviral  activity  was  neutralized  in  parallel  with 
abrogation of suppressor activity. These results provide strong evidence for the role of 
IF as a  mediator of human suppressor cell activity. 
Received  for publication 11 December 1979. 
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